Capacity for a global vaccine safety system: The perspective of national regulatory authorities

Vaccine

Volumn 30, Issue 33, 2012, Pages 4953-4959

  Graham, Janice E ^a   Borda Rodriguez, Alexander ^a   Huzair, Farah ^a   Zinck, Emily ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adverse events following immunization; Fear of reporting; Global health; Pharmacovigilance; Political will; Vaccine safety

Indexed keywords

VACCINE;

ARTICLE; DEVELOPING COUNTRY; DRUG SURVEILLANCE PROGRAM; EMPLOYMENT; GOVERNMENT; IMMUNIZATION; LOWEST INCOME GROUP; POLITICAL SYSTEM; PRIORITY JOURNAL; RISK ASSESSMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HEALTH POLICY; HUMANS; PHARMACOVIGILANCE; VACCINATION; VACCINES; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84862768110     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.045     Document Type: Article

References (62)

1. Scholz M., Duclos P. Immunization safety: a global priority. Bull World Health Organ 2000, 78(n2):153-154.
2. World Health Organization The world health report 2003, World Health Organization, Geneva.
3. Duclos P. A global perspective on vaccine safety. Vaccine 2004, 7(22):2059-2063.
4. WHO, UNICEF World Bank State of the world's vaccines and immunization 2009, WHO, Geneva, p. 32-35. 3rd ed.
5. Lieu T.A., Kulldorff M., Davis R.L., Lewis E.M., Weintraub E., Yih K., et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007, 45(10 Suppl. 2):S89-S95.
6. Canadian Paediatric Society. IMPACT, Immunization Monitoring Program ACTive. [accessed 11.11.11]. http://www.cps.ca/english/surveillance/impact/impact.htm.
7. Council for International Organizations of Medical Sciences/World Health Organization. Vaccine Pharmacovigilance. [accessed 11.11.11]. http://www.cioms.ch/activities/frame_vaccpharmadef.htm.
8. International Classification of Diseases (ICD). [accessed 11.11.11]. http://www.who.int/classifications/icd/en/.
9. Brighton Collaboration Standards. [accessed 11.11.11]. https://brightoncollaboration.org/public/what-we-do/standards.html.
10. The Uppsalla Monitoring Centre. To improve worldwide safety. [accessed 11.11.11]. http://www.who-umc.org/.
11. Hazell L., Shakir S. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006, 29:385-396.
12. Buttery J., La Vincente S., Andrews R., Kempe A., Royle J. Adverse events following immunis: desperately seeking surveillance. Lancet Infect Dis 2006, 6(November (11)):680-681.
13. Muehlhans S., Richard G., Mohammad A., Codarini G., Elemuwa C., Khamesipour A., et al. Safety reporting in developing country vaccine clinical trials - a systematic review. Vaccine 2012, 30(22):3255-3265.
14. Clemens J., Jodar L. Introducing new vaccines into developing countries: obstacle, opportunities and complexities. Nat Med 2005, 11(4):S12-S15.
15. Sanou A., Simboro S., Kouyate B., Dugas M., Graham J.E., Bibeau G. Assessment of factors associated with complete immunization coverage in children ages 12-23 months: a cross sectional study in Nouna district, Burkina Faso. BMC Int Health Human Rights 2009, 9:S10.
16. LaForce F.M., Okwo-Bele J.M. Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Aff 2011, 30:1049-1057.
17. Sow S.O., Okoko B.J., Diallo A., Viviani S., Borrow R., Carlone G., et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med 2011, 364(24):2293-2304.
18. Ouandaogo C.-R., Yaméogo T.M., Diomandé F.V., Sawadogo C., Ouédraogo B., Ouédraogo-Traoré R., et al. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine 2012, 30(Suppl. 2):B46-B51.
19. Bishai D.M., Champion C., Steele M., Thompson L. Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff 2011, 6:1058-1064.
20. World Health Organization. A system for the prequalification of vaccines for UN supply. [accessed 27.04.12]. http://www.who.int/immunization_standards/vaccine_quality/pq_system/en/index.html.
21. Global Advisory Committee on Vaccine Safety (GACVS), WHO Secretariat Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Rev Vaccines 2009, 8(June (6)):705-716.
22. The Role of National Advisory Committees in Supporting Evidence-based decision making for national immunisation programs. Vaccine 2010, 28(Suppl. 1).
23. Bryson M., Duclos P., Dolly A., Bryson J. A systematic review of national immunization policy making processes. Vaccine 2010, 28:A6-A12.
24. Bryson M., Duclos P., Jolly A., Cakmak N. A global look at national immunization technical advisory groups. Vaccine 2010, 28:A13-A17.
25. World Health Organization. Immunization safety. Global Vaccine Blueprint Project. [accessed 11.11.11]. http://www.who.int/immunization_safety/activities/GVS_blueprint_project/en/index.html.
26. Hammersley M., Atkinson P. Ethnography: principles in practice 1995, Routledge, London.
27. Wolcott H.F. Ethnography: a way of seeing 1999, Alta Mira Press, Walnut Creek, CA.
28. Low J. Unstructured interviews and health research. Health research: qualitative, quantitative and mixed methods 2007, Sage, London, UK. M. Saks, J. Allsop (Eds.).
29. Agar M. Toward a qualitative epidemiology. Qual Health Res 2003, 13:974-986.
30. Eakin J.M., Myckhalovskiy E. Reframing the evaluation of qualitative health research: reflections on a review of appraisal guidelines in health sciences. J Eval Clin Pract 2003, 9:187-194.
31. Morse J.M., Field P.A. Qualitative research methods for health professionals 1995, Sage Publications, Thousand Oaks.
32. Sapsford R., Jupp V. Social research methods 2004.
33. Thorne S. Interpretive description 2008, Left Coast Press, Walnut Creek, CA.
34. Strauss A.L., Corbin J.M. Basics of qualitative research: techniques and procedures for developing grounded theory 1998, Sage Publications Inc.
35. Boyatzis R.E. Transforming qualitative information: thematic analysis and code development 1998, Sage Publications, Thousand Oaks, CA.
36. Miles M.B., Huberman A.M. Qualitative data analysis: an expanded sourcebook 1994, Sage, Thousand Oaks, CA. 2nd ed.
37. Kvale S. Interviews: an introduction to qualitative research interviewing 1996, Sage, London.
38. Jovchelovitch S., Bauer M.W. Narrative interviewing. Qualitative researching with text, image and sound: a practical handbook 2000, 57-74. Sage, Thousand Oaks. M.W. Bauer, G. Gaskell (Eds.).
39. Palys T. Purposive sampling. The sage encyclopedia of qualitative research methods 2008, vol. 2:697-698. Sage, Thousand Oaks, CA.
40. World Bank List of Economies - as of July 18, 2011. [accessed 11.11.11]. http://www.google.ca/url%3Fsa=t%26rct=j%26q=wb%20list%20of%20economies%26source=web%26cd=2%26ved=0CCUQFjAB%26url=http%3A%2F%2Fsiteresources.worldbank.org%2FDATASTATISTICS%2FResources%2FCLASS.XLS%26ei=b9KyToGiBKT40gHDsJyvBA%26usg=AFQjCNHWuLdkFELyg0PTXBHupLnCGsB91Q.
41. Dillman D.A. Mail and internet surveys: the tailored design method 2000, Wiley, New York. 2nd ed.
42. Lincoln Y., Guba E.G. Naturalist inquiry 1985, Sage Publications, Newbury Park, CA, USA.
43. World Health Organization. Immunization service delivery: the Expanded Programme on Immunization (EPI). [accessed 11.11.11]. http://www.who.int/immunization_delivery/en/.
44. CIOMS Form Suspect Adverse reaction Report. [accessed 11.11.11]. http://www.cioms.ch/form/cioms.pdf.
45. Brighton Collaboration Case Definitions. [accessed 11.11.11]. http://vaesco.net/public/what-we-do/standards/case-definitions.html.
46. Yih W.K., Kulldorff M., Fireman B.H., Shui I.M., Lewis E.M., Klein N.P. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink Project. Pediatrics 2011, 127(May (Supp. 1)):S54-S64.
47. IMPACT. Canadian Immunization Program Act, Canadian Pediatric Society. [accessed 11.11.11]. http://www.cps.ca/english/surveillance/impact/impact.htm.
48. U.S. Food and Drug Administration (FDA). [accessed 11.11.11]. http://www.fda.gov/.
49. European Centre for Disease Prevention an Control (EuCDC). [accessed 11.11.11]. http://ecdc.europa.eu/en/Pages/home.aspx.
50. European Medicines Agency. Periodic Safety Update Reports (PSURs). [accessed 11.11.11]. http://www.ema.europa.eu/ema/index.jsp%3Fcurl=pages/regulation/q_and_a/q_and_a_detail_000041.jsp%26mid=WC0b01ac0580023e7d.
51. Therapeutics Goods Administration (TGA), Australia. [accessed 11.11.11]. http://www.tga.gov.au/.
52. Medicines and Healthcare Products Agency (MHRA), UK. [accessed 11.11.11]. http://www.mhra.gov.uk/index.htm.
53. Agência Nacional de Vigilância Sanitária (ANVISA)/National Health Surveillance Agency, Brazil. [accessed 11.11.11]. http://www.anvisa.gov.br/eng/index.htm.
54. Health Canada Regulatory mentoring to build capacity. A case study of the WHO-Canada-India Initiative. [accessed 11.11.11]. http://www.globalhealth.gov/global-health-topics/communicable-diseases/influenza/vaccine-workshops/september2010/index.html.
55. Fukuda-Parr S., Lopes C., Malik K. Capacity for development, new solutions to old problems United Nations development program 2002, United Nations Development Programme Earthscan Publications Ltd, New York.
56. Duclos P. A global perspective on vaccine safety. Vaccine 2004, 22(15-16):2059-2063.
57. Moxon E.R., Siegrist C.A. The next decade of vaccines: societal and scientific challenges. Lancet 2011, 378(9788):348-359. 23-29.
58. Avorn J. Paying for drug approvals: who's using whom. N Engl J Med 2007, 356:1697-1700.
59. Berndt E.R., Gottschalk A.H.B., Philipson T.J., Strobeck M.W. Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates. Nat Rev Drug Discov 2005, 4:545-554.
60. Gilhooley M. Drug user fees, health priorities, politics, the deficit and reform directions. Selected Works of Margaret Gilhooley. Seton-Hall University. [accessed 11.11.11]. http://works.bepress.com/margaret_gilhooley/7/.
61. James C.D., Hanson K., McPake B., Balabanova D., Gwatkin D., Hopwood I., et al. To retain or remove user fees? Reflections on the current debate in low and middle income countries. Appl Health Econ Health Policy 2006, 5:137-153.
62. IRIN News, UN Office for the Coordination of Humanitarian Affairs. West Africa: Meningitis cases dramatically down. [accessed 13.11.11]. http://www.irinnews.org/report.aspx%3FReportId=92985.